InVitro International (IVRO)

[StockLogistics]

Liquidation:

“The table below provides information regarding Officers, Directors, and Control Persons owning 5% or more of the Issuer’s equity securities as of the date of this report’s publication. As of August 1, 2022, there were 22,759,809 shares of common stock issued and outstanding, and there are 0 shares of preferred stock issued and outstanding. Percentage of ownership is based upon these amounts.
Name of Officer/Director and Control Person
Affiliation with Company (e.g. Officer/Director/Owner of more than 5%)
Residential Address (City / State Only)
Number of shares owned
Share type/class
Ownership Percentage of Class Outstanding
W. Richard Ulmer 2, 5 Cathy L. Richmond 3
Irwin J. Gruverman 4 Atul Jhalani 1
Dennis E. Chenoweth, M.D., PhD
Sean Adrean, M.D.
Chief Executive Officer, and Chairman
Chief Financial Officer, and Director
Chairman Emeritus President Director Director
Villa Park, CA Indio, CA
Auburndale, MA Yorba Linda, CA Ventura, CA
Villa Park, CA
Total:
2,800,000 700,000 1,300,676 500,000 1,100,000 0
8,035,676
Common Common Common Common Common Common
Common
12.31% 3.08% 5.72% 2.20% 4.84% 0%
35.34%
Note
Steven A. Pitassi 6
Catherine M. Pitassi Rev. Trust Established September 30, 2019 (1,110,000 shares) Stephanie Sarro, daughter (525,000 shares)
Director
North Providence, RI
1,635,000 (Indirect beneficial ownership)
Common
7.19%
“

“As of June 30, 2022, the Company moved all securities to an investment holding account to convert into cash and cash equivalents; the total liquidation occurred in July 2022 with miscellaneous monies in the money market accounts.”

https://www.otcmarkets.com/otcapi/company/financial-report/341741/content